|Year : 2022 | Volume
| Issue : 2 | Page : 194-195
Fluorodeoxyglucose Positron Emission Tomography Imaging in Pneumocystis jiroveci Pneumonia
Hemant Rathore1, Nirav Thaker2, Inder Talwar2
1 Department of Nuclear Medicine and PET CT, Bombay Hospital and Medical Research Centre, Mumbai, Maharashtra, India
2 Department of Radiodiagnosis, Bombay Hospital and Medical Research Centre, Mumbai, Maharashtra, India
|Date of Submission||15-Sep-2021|
|Date of Acceptance||04-Oct-2021|
|Date of Web Publication||08-Jul-2022|
Dr. Hemant Rathore
Department of Nuclear Medicine and PET CT, Bombay Hospital and Medical Research Centre, 12 Marine Lines, Mumbai - 400 020, Maharashtra
Source of Support: None, Conflict of Interest: None
| Abstract|| |
Fever or pyrexia of unknown origin (PUO) is commonly defined as body temperature higher than 38.3°C on several occasions for a period of at least 3 weeks with uncertain diagnosis after initial routine obligatory investigations. In most cases of PUO, there is an uncommon presentation of a common disease which includes infection, noninfectious inflammatory diseases, malignancy, and miscellaneous causes. We present an interesting case of a 48-year-old man with PUO, who is a known case of multiple myeloma on immunosuppressive therapy, where 18F-fluorodeoxyglucose positron emission tomography-computed tomography was able to detect occult cause of infective etiology.
Keywords: 18F-fluorodeoxyglucose, Pneumocystis carinii, Pneumocystis jiroveci pneumonia, positron emission tomography-computed tomography, pyrexia of unknown origin
|How to cite this article:|
Rathore H, Thaker N, Talwar I. Fluorodeoxyglucose Positron Emission Tomography Imaging in Pneumocystis jiroveci Pneumonia. Indian J Nucl Med 2022;37:194-5
|How to cite this URL:|
Rathore H, Thaker N, Talwar I. Fluorodeoxyglucose Positron Emission Tomography Imaging in Pneumocystis jiroveci Pneumonia. Indian J Nucl Med [serial online] 2022 [cited 2022 Aug 8];37:194-5. Available from: https://www.ijnm.in/text.asp?2022/37/2/194/350252
| Background and Procedure|| |
We describe a case of a 48-year-old man with pyrexia of unknown origin (PUO), who is a known case of multiple myeloma on immunosuppressive therapy, with remission of disease on recent bone marrow examination. This case presented with dry cough and fever over 4 weeks (100°F–102°F) and had an oxygen saturation of 97% on ambient air. The blood tests apart from mild leukopenia were fairly unremarkable. The chest radiography revealed subtle bilateral lung ground-glass opacities and referred for fluorodeoxyglucose positron emission tomography (FDG-PET)/computed tomographic (CT) scan to rule out the cause. The FDG-PET scan [Figure 1] revealed diffuse increased metabolic activity in bilateral lungs; the corresponding fused high-resolution CT (HRCT) images showed the acute lung changes in the form of hypermetabolic ill-defined confluent ground-glass opacities with interstitial thickening and crazy paving appearance near completely involving bilateral lungs along with mild bronchial and bronchiolar dilatation [Figure 2]. The imaging was suggestive of acute atypical pneumonia which was further investigated by bronchoalveolar lavage cytological examination and culture which demonstrated Pneumocystis jiroveci.
|Figure 1: Whole-body fluorodeoxyglucose positron emission tomography scan maximum intensity projection image reveals diffuse increased metabolic activity in bilateral lungs with physiological fluorodeoxyglucose uptake in rest of the visualized body|
Click here to view
|Figure 2: High-resolution computed tomography (left), and fused fluorodeoxyglucose positron emission tomography and high-resolution computed tomography (right) images reveals hypermetabolic ill-defined confluent ground-glass opacities with interstitial thickening near completely involving bilateral lungs|
Click here to view
Pneumocystic jiroveci pneumonia (PJP), is also known as pneumocystic pneumonia or formerly pneumocystic carinii pneumonia, is caused by the ubiquitous unicellular eukaryote, P jiroveci, which is a rare cause of infection in the general population, but it is a more frequent cause of morbidity and mortality in immunocompromised persons who are especially with HIV AIDS, postorgan-transplant recipients, and those receiving long-term cytotoxic or steroid therapy, hematological malignancies, as well as other malignancies. PJP is classified as a fungal pneumonia but does not respond to antifungal therapy. These patients have a long clinical course over months to years, with stable symptoms and radiographic abnormalities corresponding to pathologic findings of traction bronchiectasis, honeycombing, and interstitial fibrosis.
In a study of 105 pneumocystic pneumonia immunocompromised patients, chest radiographic findings were divided into three stages: early stage; normal or nearly normal chest radiograph, mid-stage; bilateral pulmonary infiltrates, and late stage; bilateral pulmonary consolidation. Chest HRCT findings were also divided into three stages: early stage; bilateral diffuse ground-glass opacity, mid-stage; bilateral diffuse ground-glass opacity with patchy consolidations, and late stage; bilateral diffuse consolidation).
| Conclusion|| |
FDG-PET/CT imaging is a very sensitive diagnostic modality for the evaluation of fever of unknown origin by facilitating anatomical localization of focally increased FDG uptake and thereby guiding further diagnostic tests to achieve a final diagnosis. Few studies suggest that FDG-PET scan have an important role to play in the diagnosis and monitoring treatment response of pneumocystic pneumonia in the immunocompromised patients.
Financial support and sponsorship
Conflicts of interest
There are no conflicts of interest.
| References|| |
Bollée G, Sarfati C, Thiery G, Bergeron A, de Miranda S, Menotti J, et al.
Clinical picture of Pneumocystis jiroveci
pneumonia in cancer patients. Chest 2007;132:1305-10.
Mu XD, Jia P, Gao L, Su L, Zhang C, Wang RG, et al.
Relationship between radiological stages and prognoses of pneumocystis pneumonia in non-AIDS immunocompromised patients. Chin Med J (Engl) 2016;129:2020-5.
Kouijzer IJ, Mulders-Manders CM, Bleeker-Rovers CP, Oyen WJ. Fever of unknown origin: The value of FDG-PET/CT. Semin Nucl Med 2018;48:100-7.
Win Z, Todd J, Al-Nahhas A. FDG-PET imaging in Pneumocystis carinii
pneumonia. Clin Nucl Med 2005;30:690-1.
[Figure 1], [Figure 2]